Qiagen names new CEO as private equity sale talks advance
Qiagen has appointed Jonathan Pratt as CEO, bringing in an executive with recent experience overseeing a multibillion-dollar sale as the European molecular diagnostics company considers a potential takeover by private equity firms, according to a report by Bloomberg.
Original Source
Read the full article at Privateequitywire →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.